Belpointe Asset Management LLC Abbott Laboratories Transaction History

Belpointe Asset Management LLC

$1.28 Billion
Q2 2024

A detailed history of Belpointe Asset Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Belpointe Asset Management LLC holds 27,652 shares of ABT stock, worth $3.14 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

27,652

Previous 27,938 1.02%

Holding current value

$3.14 Million

Previous $3.18 Million 9.51%

% of portfolio

0.22%

Previous 0.26%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$100.73 - $112.44 $28,808 - $32,157	-286 Reduced 1.02%	27,652 $2.87 Million
Q1 2024 May 08, 2024	BUY	$109.52 - $120.96 $105,029 - $116,000	959 Added 3.55%	27,938 $3.18 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $20,924 - $25,612	232 Added 0.87%	26,979 $2.97 Million
Q3 2023 Nov 15, 2023	SELL	$95.53 - $114.62 $72,125 - $86,538	-755 Reduced 2.75%	26,747 $2.59 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $930,804 - $1.04 Million	-9,236 Reduced 25.14%	27,502 $3 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $148,002 - $174,207	1,528 Added 4.34%	36,738 $3.72 Million
Q4 2022 Feb 08, 2023	SELL	$95.06 - $111.52 $170,917 - $200,512	-1,798 Reduced 4.86%	35,210 $3.87 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $308,277 - $356,927	3,186 Added 9.42%	37,008 $3.58 Million
Q2 2022 Aug 02, 2022	BUY	$102.07 - $123.37 $97,783 - $118,188	958 Added 2.92%	33,822 $3.68 Million
Q1 2022 Apr 28, 2022	BUY	$114.02 - $139.04 $206,376 - $251,662	1,810 Added 5.83%	32,864 $3.89 Million
Q4 2021 Feb 15, 2022	SELL	$115.53 - $141.46 $921,929 - $1.13 Million	-7,980 Reduced 20.44%	31,054 $4.37 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $844,035 - $933,749	7,235 Added 22.75%	39,034 $4.61 Million
Q2 2021 Aug 09, 2021	BUY	$105.79 - $124.53 $206,502 - $243,082	1,952 Added 6.54%	31,799 $3.69 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $273,514 - $322,241	-2,513 Reduced 7.77%	29,847 $3.58 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $482,475 - $525,759	-4,595 Reduced 12.43%	32,360 $3.54 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $14,570 - $17,695	-159 Reduced 0.49%	32,098 $2.53 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $445,095 - $540,535	4,857 Added 15.13%	36,955 $4.02 Million
Q2 2020 Jul 20, 2020	BUY	$76.57 - $98.0 $12,174 - $15,582	159 Added 0.5%	32,257 $2.95 Million
Q1 2020 Jul 20, 2020	SELL	$62.82 - $91.86 $64,139 - $93,789	-1,021 Reduced 3.08%	32,098 $2.53 Million
Q4 2019 Feb 18, 2020	BUY	$78.51 - $87.4 $419,321 - $466,803	5,341 Added 19.23%	33,119 $2.88 Million
Q3 2019 Jan 16, 2020	BUY	$81.84 - $88.74 $14,731 - $15,973	180 Added 0.65%	27,778 $2.32 Million
Q2 2019 Nov 22, 2019	SELL	$72.88 - $85.0 $124,041 - $144,670	-1,702 Reduced 5.81%	27,598 $0
Q1 2019 Jun 11, 2019	BUY	$66.22 - $80.06 $298,122 - $360,430	4,502 Added 18.15%	29,300 $2.34 Million
Q4 2018 Mar 06, 2019	SELL	$65.56 - $74.27 $9,571 - $10,843	-146 Reduced 0.59%	24,798 $1.79 Million
Q3 2018 Nov 23, 2018	BUY	$60.81 - $73.36 $134,937 - $162,785	2,219 Added 9.76%	24,944 $1.83 Million
Q2 2018 Aug 06, 2018	BUY	$57.57 - $63.54 $2,072 - $2,287	36 Added 0.16%	22,725 $1.39 Million
Q1 2018 Aug 06, 2018	SELL	$56.27 - $63.62 $98,585 - $111,462	-1,752 Reduced 7.17%	22,689 $1.36 Million
Q4 2017 Feb 15, 2018	BUY	$53.68 - $57.47 $26,678 - $28,562	497 Added 2.08%	24,441 $1.4 Million
Q3 2017 Nov 16, 2017	BUY	$48.06 - $53.64 $1.15 Million - $1.28 Million	23,944	23,944 $1.28 Million

Others Institutions Holding ABT

# of Institutions

3,136

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belpointe Asset Management LLC with notifications on news.

Account

Belpointe Asset Management LLC Abbott Laboratories Transaction History